当前位置: X-MOL 学术AIDS Behav. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Mental Health, Social Influences, and HIV Pre-exposure Prophylaxis (PrEP) Utilization Among Men and Transgender Individuals Screening for HIV Prevention Trials
AIDS and Behavior ( IF 2.7 ) Pub Date : 2020-08-28 , DOI: 10.1007/s10461-020-03004-y
Sarah M Wood 1, 2, 3 , Knashawn H Morales 2 , David Metzger 2 , Annet Davis 2 , Danielle Fiore 2 , Danielle Petsis 1 , Kezia Barnett 1 , Helen C Koenig 2 , Nadia Dowshen 1, 2 , Robert Gross 2 , Ian Frank 2
Affiliation  

The effects of mental health comorbidities and social support on the HIV pre-exposure prophylaxis (PrEP) care continuum are unknown. We conducted a cross-sectional study of men and transgender individuals, ≥ 18 years-old, with ≥ 2 male or transgender partners, or recent condomless anal intercourse. Surveys assessed demographics, mental health treatment, depressive symptomatology, social support, and PrEP-related social contacts. Logistic regression assessed associations between these factors and PrEP uptake and persistence. Participants (n = 247) were 89% cis-male and 46% African-American. Median age was 27 (IQR:23–33). Thirty-seven percent had ever used PrEP, of whom 18% discontinued use. High depressive symptomology was identified in 11% and 9% were receiving mental health treatment. There were no significant associations between depressive symptoms or mental health treatment on the odds of PrEP uptake or discontinuation. Each additional PrEP contact conferred a greater odds of uptake (aOR:1.24, 95% CI: 1.09–1.42). Network-level targets may produce fruitful interventions to increase PrEP uptake.



中文翻译:

男性和跨性别者的心理健康、社会影响和 HIV 暴露前预防 (PrEP) 使用情况 HIV 预防试验筛查

心理健康合并症和社会支持对 HIV 暴露前预防 (PrEP) 护理连续性的影响尚不清楚。我们对年龄≥ 18 岁、有≥ 2 个男性或变性伴侣、或最近进行过无套肛交的男性和变性个体进行了一项横断面研究。调查评估了人口统计、心理健康治疗、抑郁症状、社会支持和 PrEP 相关的社会接触。逻辑回归评估了这些因素与 PrEP 摄取和持久性之间的关联。参与者 (n = 247) 89% 是顺式男性,46% 是非裔美国人。中位年龄为 27 岁(IQR:23-33)。37% 的人曾经使用过 PrEP,其中 18% 停止使用。11% 的人患有高度抑郁症状,9% 的人正在接受心理健康治疗。抑郁症状或心理健康治疗与 PrEP 服用或停止的几率之间没有显着关联。每增加一次 PrEP 接触都会带来更大的摄取几率(aOR:1.24,95% CI:1.09–1.42)。网络级目标可能会产生富有成效的干预措施,以提高 PrEP 的采用率。

更新日期:2020-08-28
down
wechat
bug